Can insulin signaling pathways be targeted to transport Aβ out of the brain?
Authors:
Open Access
- 16 June 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 7, 114
Abstract
Although the causal role of Amyloid-β (Aβ) in Alzheimer’s disease (AD) is unclear, it is still reasonable to expect that lowering concentrations of Aβ in the brain may decrease the risk of developing the neurocognitive symptoms of the disease. Brain capillary endothelial cells forming the blood-brain barrier (BBB) express transporters regulating the efflux of Aβ out of the cerebral tissue. Age-related BBB dysfunctions, that have been identified in AD patients, might impair Aβ clearance from the brain. Thus, targeting BBB outward transport systems has been suggested as a way to stimulate the clearance of Aβ from the brain. Recent data indicate that the increase in soluble brain Aβ and behavioral impairments in 3xTg-AD mice generated by months of intake of a high-fat diet can be acutely reversed by the administration of a single dose of insulin. A concomitant increase in plasma Aβ suggests that clearance from the brain through the BBB is a likely mechanism for this rapid effect of insulin. Here, we review how BBB insulin signaling pathways could be stimulated to decrease brain Aβ concentrations and improve cognitive performance, at least on the short term.Keywords
This publication has 186 references indexed in Scilit:
- Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical EvidenceCNS Drugs, 2013
- Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetesJournal of Diabetes and its Complications, 2012
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2012
- Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm ShiftNeuron, 2011
- Cognition, reserve, and amyloid deposition in normal agingAnnals of Neurology, 2010
- Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ ClearanceNeuron, 2009
- Cerebrovascular Responses to Insulin in RatsJournal of Cerebral Blood Flow & Metabolism, 2009
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer diseaseNeurobiology of Aging, 2009
- Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's diseaseBrain Research, 2008
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991